Zerga, M. “New Therapeutic Options for relapsed/Refractory Diffuse Large B-Cell Lymphoma. Treatment With Tafasitamab + Lenalidomide”. Journal of Hematology, vol. 29, no. 3, Jan. 2026, pp. 61-70, doi:10.48057/hematologa.v29i3.687.